Growing expertise in Biosimilars

Growing expertise in Biosimilars

Since our foray into Biosimilar products in 2009, we have been developing cost-effective biosimilars using our strong research base and cutting-edge technology. Through our single-use and state-of-the art manufacturing site, we have launched niche and complex products in the shortest possible time, benefitting the end-user.

A dedicated biologics arm Hetero Biopharma, catering to Indian and emerging markets

Launched 5 biosimilar products

State-of-the-art, single use manufacturing facility and dedicated R&D wing, meeting US FDA and EU standards

Explore more

Know more about our CPS

Got a business query?